1. Home
  2. TECX
  3. TECX News

Latest Tectonic Therapeutic Inc. Common Stock (TECX) News on August 16, 2025

Tectonic Therapeutic Joins Russell 3000® Index
TECX

GlobeNewswire

2 months ago

Tectonic Therapeutic Joins Russell 3000® Index

Raymond James Resumes Coverage of Tectonic Therapeutic (TECX) With an Outperform Rating
TECX

Insider Monkey

2 months ago

Raymond James Resumes Coverage of Tectonic Therapeutic (TECX) With an Outperform Rating

We Think Tectonic Therapeutic (NASDAQ:TECX) Can Afford To Drive Business Growth
TECX

Simply Wall St.

2 months ago

We Think Tectonic Therapeutic (NASDAQ:TECX) Can Afford To Drive Business Growth

Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025
TECX

GlobeNewswire

3 months ago

Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025

Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights
TECX

GlobeNewswire

3 months ago

Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights

Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference
TECX

GlobeNewswire

3 months ago

Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference

Insider Stock Buying Reaches US$62.6m On Tectonic Therapeutic
TECX

Simply Wall St.

3 months ago

Insider Stock Buying Reaches US$62.6m On Tectonic Therapeutic

TipRanks’ ‘Perfect 10’ Picks: 2 Top-Scoring Stocks Earning Wall Street’s Seal of Approval
TECX

TipRanks

4 months ago

TipRanks’ ‘Perfect 10’ Picks: 2 Top-Scoring Stocks Earning Wall Street’s Seal of Approval

Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025
TECX

GlobeNewswire

4 months ago

Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025

TECX

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 04/14/2025

TECX

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 04/10/2025

Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
TECX

GlobeNewswire

5 months ago

Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Tectonic Therapeutic to Participate in March Investor Conferences
TECX

GlobeNewswire

6 months ago

Tectonic Therapeutic to Participate in March Investor Conferences

Tectonic Announces $185 Million Private Placement
TECX

GlobeNewswire

6 months ago

Tectonic Announces $185 Million Private Placement

Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF
TECX

GlobeNewswire

7 months ago

Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF

Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024
TECX

GlobeNewswire

8 months ago

Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024

Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference
TECX

GlobeNewswire

9 months ago

Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference

Tectonic Therapeutic Inc. Reports Q3 2024 Results
TECX

TipRanks

9 months ago

Tectonic Therapeutic Inc. Reports Q3 2024 Results

Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein
TECX

GlobeNewswire

9 months ago

Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein

Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights
TECX

GlobeNewswire

9 months ago

Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights

Tectonic Therapeutic Independent Director Acquires 7.0% More Stock
TECX

Simply Wall St.

10 months ago

Tectonic Therapeutic Independent Director Acquires 7.0% More Stock

Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
TECX

GlobeNewswire

10 months ago

Tectonic Therapeutic to Present Phase 1a Data at AHA 2024

TECX

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 09/27/2024

Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans
TECX

Simply Wall St.

a year ago

Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans

Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45
TECX

GlobeNewswire

a year ago

Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45

Tectonic Therapeutic to Participate in September Investor Conferences
TECX

GlobeNewswire

a year ago

Tectonic Therapeutic to Participate in September Investor Conferences

Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights
TECX

GlobeNewswire

a year ago

Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights

Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45
TECX

GlobeNewswire

a year ago

Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45

Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as Concurrent Private Placement of $130.7 Million
TECX

Business Wire

a year ago

Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as Concurrent Private Placement of $130.7 Million

Share on Social Networks: